Diagnostic accuracy of computed tomography-guided biopsy in pathological fractures.
Stokes CM et al. ANZ J Surg. 2017 Mar 17. doi: 10.1111/ans.13894. [Epub ahead of print].

Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
Dutoit JC et al. Skeletal Radiol. 2017 Mar 13. doi: 10.1007/s00256-017-2609-6. [Epub ahead of print].

CXCR4 (CD184) expression on stem cell harvest and CD34+ cells post-transplant.
Asfour I et al. Hematol Oncol Stem Cell Ther. 2017 Mar 2. pii: S1658-3876(17)30009-2. doi: 10.1016/j.hemonc.2017.01.002. [Epub ahead of print].

The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients.
Ceran F et al. Turk J Haematol. 2017 Mar 8. doi: 10.4274/tjh.2016.0394. [Epub ahead of print].

Automated “Bone Subtraction” Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma.
Horger M et al. Acad Radiol. 2017 Feb 27. pii: S1076-6332(16)30424-X. doi: 10.1016/j.acra.2016.12.003. [Epub ahead of print].

Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukaemia definition.
Granell M et al. Haematologica. 2017 Mar 2. pii: haematol.2016.158303. doi: 10.3324/haematol.2016.158303. [Epub ahead of print].